Christie Group PLC
01 October 2026
1 October 2026
Christie Group plc
("Christie Group" or the "Company")
Christie & Co publishes Pharmacy Market Review 2026
Annual review highlights continued transaction activity and improved operator performance
Christie Group plc (CTG.L) reports that its agency and advisory business, Christie & Co, has published its Pharmacy Market Review 2026, which shares insights into the UK pharmacy market, drawing on Christie & Co's transactional and valuation activity data, alongside insights from operators across England, Scottland and Wales.
The report illustrates improving financial performance across the pharmacy sector, alongside continued transaction activity.
Building on growing momentum in recent years, Christie & Co advised on, agreed or sold 1,145 pharmacies with a combined value of more than £724 million in across H2 2025 and H1 2026, demonstrating the continued transaction activity in the sector.
Demand for valuation services in the sector also remained strong. Christie & Co completed 312 pharmacy valuation instructions in 2025, up 68% compared to 2024. These volumes have remained strong into 2026, with Christie & Co completing 128 instructions in the first half of the year.
Recent funding uplifts have also supported improved financial performance and profitability across the sector. Christie & Co's analysis found that average gross profit margins increased to 34.6% in H1 2026, while EBITDA margins rose from 9.2% to 11.5%. Pharmacies continue to improve efficiency and expand their clinical and private healthcare services.
The review also points to continued transaction appetite. Christie & Co's survey of operators indicated that three-quarters (75%) plan to either buy or sell a pharmacy within the next three years, while a further 39% identified acquiring a pharmacy as a key growth opportunity.
Christie & Co's market leading Pharmacy team provides brokerage, valuation and consultancy services across the sector. Christie Finance, Christie Insurance and Pinders offer complementary services.
The publication is available to read on www.christie.com, or can be found by following the link below:
· Pharmacy Market Review 2026 | Christie & Co
Dan Prickett, Chief Executive of Christie Group plc, comments: "Activity across the pharmacy market remains strong, supported by improving operator profitability and continued demand from buyers. Across H2 2025 and H1 2026, Christie & Co advised on, agreed or sold 1,145 pharmacies worth more than £724 million, while demand for our valuation services also remains strong. With three-quarters of operators surveyed planning to buy or sell over the next three years, we see continued opportunities for Christie & Co, Christie Finance, Christie Insurance and Pinders to support clients across the sector as momentum continues."
Enquiries:
Christie Group plc
Dan Prickett 07885 813101
Chief Executive
Simon Hawkins 07767 354366
Chief Financial Officer
Shore Capital
Patrick Castle 020 7408 4090
Nominated Advisor and Broker
Hudson Sandler
Alex Brennan / Emily Brooker 020 7796 4133/christiegroup@hudsonsandler.com
Financial PR
Notes to Editors:
Christie Group plc, quoted on AIM, is a leading professional business services group with 32 offices across the UK and Europe, catering to its specialist markets in the healthcare, hospitality, leisure, medical, childcare & education and retail sectors.
Christie Group operates in two complementary business divisions: Professional & Financial Services (PFS) and Stock & Inventory Systems & Services (SISS). These divisions trade under the brand names: PFS - Christie & Co, Pinders, Christie Finance and Christie Insurance: SISS - Venners.
Tracing its origins back to 1896, the Group has a long-established reputation for offering valued services to client companies in agency, valuation services, investment, consultancy, project management, stock audit and inventory management. The diversity of these services provides a natural balance to the Group's core agency business.
For more information, please go to https://www.christiegroup.com/
More about our services:
https://www.christie.com/ https://www.christieinsurance.com/ https://www.christiefinance.com https://www.pinders.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.